Ariad Boosts Cash by $69M in Revised Deal with Partner Merck May 6, 2010 By Catherine Hollingsworth No Comments
Affimed Plans to Take Antibodies into Clinic with $26M Series C May 5, 2010 By Catherine Hollingsworth No Comments
Protox's $75M Kissei Deal May Set Stage for Larger Alliances May 5, 2010 By Catherine Hollingsworth No Comments
Salix's Phase III Bowel Drug Shows Sustained Relief of IBS May 5, 2010 By Catherine Hollingsworth No Comments
Middlebrook Shares Take a Hit as Firm Seeks Bankruptcy Relief May 4, 2010 By Catherine Hollingsworth No Comments
Protox's $75M Kissei Deal May Set Stage for Larger Alliances May 3, 2010 By Catherine Hollingsworth No Comments
Affimed Plans to Take Antibodies into Clinic with $26M Series C April 30, 2010 By Catherine Hollingsworth No Comments
Lycera's Progress Triggers $11M in Second Part of Series A Round April 29, 2010 By Catherine Hollingsworth No Comments
YM Could Bring in Up to $7.75M in Controlled Equity Financing April 28, 2010 By Catherine Hollingsworth No Comments
Garnet Seeking Additional Funds to Advance Lead Cell Therapy April 27, 2010 By Catherine Hollingsworth No Comments
